wzb117 has been researched along with Gastrointestinal-Stromal-Tumors* in 1 studies
1 other study(ies) available for wzb117 and Gastrointestinal-Stromal-Tumors
| Article | Year |
|---|---|
Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Glucose Transporter Type 1; Humans; Hydroxybenzoates; Imatinib Mesylate | 2022 |